Pfizer is trading like it caught a cold, despite showing strong financial health post-COVID. In Q4 2024, Pfizer raked in ...

By looking at Uber's ( UBER 0.91%) stock chart, you'll quickly notice how volatile the journey has been for investors. In the ...

Net Loss: The net loss attributable to Serina for the year ended December 31, 2024 was $11.1 million, or $ (1.51) per basic and diluted share, compared to net income of $5.3 million, or $2.36 per ...

We recently published a list of 14 Best Affordable Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Of late, pharmaceutical behemoth Pfizer Inc.’s PFE stock has struggled, but it remains a bargain with generous dividends. Its ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

China is making efforts to highlight the country’s business opportunities to major American corporations like Apple (AAPL), ...

Oracle has delivered impressive gains in the past five years. Oracle sees faster growth over the next few years thanks to its ...

Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher ...

How GLP-1 drugs, regulatory concerns, and more factors are shaping the sector. Plus, 3 undervalued healthcare stocks.

Learn more about whether Recursion Pharmaceuticals, Inc. or Zai Lab Limited is a better investment based on AAII's A+ ...

Four Goldman Sachs stock picks make sense for growth and income investors charting a course for the rest of what could be a ...